FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

CDER Creates Internal AI Council

CDER creates a new internal Artificial Intelligence Council to oversee, coordinate, and consolidate all Center AI activities.

latest-news-card-1
Human Drugs

Nuvectis Gets Orphan Status for NXP800

FDA grants Nuvectis Pharma an orphan drug designation for NXP800 and its use in treating ovarian, fallopian tube, and primary peritoneal cancers.

latest-news-card-1
Medical Devices

Renata Expandable Growth Stent OKd for Infants

FDA approves a Renata Medical PMA for its Minima Growth Stent thats intended for treating congenital heart disease in infants and young children.

latest-news-card-1
Biologics

Liveyon Founder Pleads Guilty

Liveyon founder and CEO John Kosolcharoen pleads guilty to a felony charge of introducing an unapproved new stem cell product into interstate commerce...

latest-news-card-1
Medical Devices

Malfunction Reporting Program Guidance

FDA publishes a guidance describing and clarifying several aspects of the Voluntary Malfunction Summary Reporting program.

latest-news-card-1
Human Drugs

Require More Breakthrough Postmarket Studies: Research

Researchers call on FDA to require postmarketing studies for breakthrough therapy-designated drugs studied with surrogate endpoints for traditional ap...

latest-news-card-1
Medical Devices

Abbott Class 1 Recall of FreeStyle Libre Sensors

Abbott Diabetes Care begins a Class 1 recall (device correction) of its FreeStyle Libre 3 sensors based on users reporting situations where they were ...

latest-news-card-1
Human Drugs

Global Calcium India Facility Hit with FDA-483

An FDA inspection of a Global Calcium manufacturing facility in Hosur, India leads to a six-observation Form FDA-483 that cites significant GMP violat...

latest-news-card-1
Federal Register

Exelas Fentanyl Not Withdraw Over Safety/Efficacy

Federal Register notice: FDA determines that Exela Pharma Sciences fentanyl citrate injections, equivalent to 2.5mg/50mL and 5mg/100mL (EQ 0.05 mg bas...

latest-news-card-1
Federal Register

Mirum Pharma Wins Priority Review Voucher

Federal Register notice: FDA announces that it issued Mirum Pharmaceuticals a priority review voucher for its approved rare pediatric disease product ...